Compare MASI & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MASI | ACHC |
|---|---|---|
| Founded | 1989 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 1.3B |
| IPO Year | 2007 | N/A |
| Metric | MASI | ACHC |
|---|---|---|
| Price | $131.09 | $14.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 13 |
| Target Price | ★ $188.80 | $24.00 |
| AVG Volume (30 Days) | 762.4K | ★ 3.3M |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.18 |
| Revenue | $2,182,000,000.00 | ★ $3,265,548,000.00 |
| Revenue This Year | N/A | $6.50 |
| Revenue Next Year | $6.83 | $4.38 |
| P/E Ratio | ★ N/A | $12.46 |
| Revenue Growth | ★ 38.48 | 4.58 |
| 52 Week Low | $131.47 | $12.63 |
| 52 Week High | $194.88 | $47.08 |
| Indicator | MASI | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 35.86 | 40.10 |
| Support Level | $131.47 | $14.05 |
| Resistance Level | $137.79 | $14.76 |
| Average True Range (ATR) | 3.40 | 0.53 |
| MACD | -0.50 | 0.24 |
| Stochastic Oscillator | 1.00 | 63.73 |
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.